Sana Biotechnology Inc Inc. (SANA) Price Performance: The Role of Supply and Demand

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -26.86% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 31.31%. Over the past 30 days, the price of SANA has fallen by 57.47%. And in the last five days, it has fallen by -9.14%.

The stock of Sana Biotechnology Inc (SANA) is currently priced at $4.43. In the last session, the stock climbed significantly, topping out at $15.0 after opening at $4.46. The day’s lowest price was $5.0 before the stock closed at $4.88.

Sana Biotechnology Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $7.30 on 01/08/25 and the lowest value was $1.26 on 04/04/25.

52-week price history of SANA Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Sana Biotechnology Inc’s current trading price is -39.38% away from its 52-week high, while its distance from the 52-week low is 251.19%. The stock’s price range during this period has varied between$1.26 and $7.30. The Sana Biotechnology Inc’s shares, which operate in the Healthcare, saw a trading volume of around 3.13 million for the day, a figure considerably lower than their average daily volume of 4.81 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Sana Biotechnology Inc (SANA) has experienced a quarterly rise of 151.42% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 998.08M and boasts a workforce of 194 employees.

Sana Biotechnology Inc: Analysts’ Ratings Unveiled

As of right now, 4 analysts are rating Sana Biotechnology Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.54, with a change in price of +1.92. Similarly, Sana Biotechnology Inc recorded 4,400,880 in trading volume during the last 100 days, posting a change of +75.49%.

SANA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SANA stands at 0.44. Similarly, the long-term debt-to-equity ratio is also 0.37.

SANA Stock Stochastic Average

As of today, Sana Biotechnology Inc’s raw stochastic average for the last 50 days stands at 76.92%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 68.68%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 79.43% and 86.25%, respectively.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.